Form 4 for PCVX Vaxcyte, Inc.
Accepted 2022-02-28 00:00:00 ET · period of report 2022-02-24 · accession 0001209191-22-013687 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-28 | 2022-02-24 | PCVX | Wassil Jim | COO | S - Sale+OE | $22.00 | -10.0K | 17.9K | -36% | -$220.0K |
| D | 2022-02-28 | 2022-02-24 | PCVX | Wassil Jim | COO | M - OptEx | $2.42 | +10.0K | 27.9K | +56% | +$24.2K |
| D | 2022-02-28 | 2022-02-24 | PCVX | Wassil Jim | COO | M - OptEx | $0.00 | -10.0K | 235.9K | -4% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-24 | S | D | 10,000 | $22.00 | 17,944 | D | — | — | |
| 2 | Common | Common Stock | 2022-02-24 | M | A | 10,000 | $2.42 | 27,944 | D | — | — | (F1) Includes 1,563 shares acquired under the Issuer's Employee Stock Purchase Plan on May 17, 2021. |
| 3 | Derivative | Stock Option (right to buy) | 2022-02-24 | M | D | 10,000 | $0.00 | 235,926 | D | $2.42 · — to 2029-12-16 | 10,000 Common Stock | (F3) 1/4 of the shares subject to the option vested on December 1, 2020, and 1/48 of the shares vest monthly thereafter. |